BridGene Biosciences
BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules. It enables covalent small molecules to perform proteome-wide screening in live cells, which results in highly selective small molecules that drug traditionally undruggable targets.
Domain
bridgenebio.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$28.0M
Founded
2017
Tech Stack (2 technologies)
Frequently Asked Questions
What technologies does BridGene Biosciences use?+
BridGene Biosciences uses 2 technologies including Vue.js, UnoCSS.
What industry is BridGene Biosciences in?+
BridGene Biosciences operates in the Biotechnology industry.
Where is BridGene Biosciences based?+
BridGene Biosciences is headquartered in United States.
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026